What Is Lupus?

What This Article Covers

Lupus is a chronic autoimmune disease in which the immune system turns against the body's own healthy tissue. This article explains what lupus is, who it affects, what is known about its causes, how it presents and is diagnosed, and the standard treatments used today — closing with a brief look at where stem cell and cell-based research currently stands, a topic covered in much greater depth in our dedicated deep-dive article, Stem Cell Therapy for Lupus.

What Lupus Actually Is

Systemic lupus erythematosus (SLE) is the most common and typically most serious form of lupus, and the one most people mean by the word. In SLE, the immune system produces autoantibodies that mistakenly attack the body's own cells, triggering inflammation that can affect the skin, joints, kidneys, heart, lungs, blood cells, and brain. Because nearly any organ can be involved and the disease looks different person to person, lupus is sometimes called a disease of a thousand faces. Less common related forms include cutaneous lupus (skin only) and drug-induced lupus (usually reversible). Lupus is chronic with no cure, but it is not static: most people cycle through flares, when activity intensifies, and remission, when symptoms ease.

Who Lupus Affects

Lupus is far from rare: an estimated 1.5 million Americans and at least 5 million people worldwide live with some form of it, per the Lupus Foundation of America. About 90% of those diagnosed are women, with onset most common between ages 15 and 44. The burden falls unevenly along racial and ethnic lines — lupus is two to three times more prevalent among Black, Hispanic/Latina, Native American, Alaska Native, and Native Hawaiian women than among white women, and these groups tend to develop it earlier, with more severe complications and higher mortality.

What Causes Lupus

The exact cause remains unknown. NIAMS attributes lupus to factors that together cause the immune system to misfire: genetic susceptibility, hormonal influences (helping explain its skew toward women), and environmental triggers such as viral infections, ultraviolet light, certain medications, and smoking. No single gene or exposure causes lupus alone — it appears to take inherited risk plus environmental triggers acting together.

Common Symptoms

Symptoms vary widely and can come and go. By far the most common is fatigue — a profound tiredness affecting physical function, mental clarity, and daily life even when other symptoms are quiet. Other frequent symptoms include joint and muscle pain or swelling, low-grade fever, hair loss, and mouth sores. A hallmark but not universal sign is a butterfly-shaped facial rash, along with sun sensitivity. More serious manifestations include chest pain with deep breathing, Raynaud's phenomenon (fingers or toes turning white or blue in cold), blood clotting abnormalities, and effects on the kidneys, heart, lungs, or nervous system. One of the most serious complications is lupus nephritis — kidney inflammation caused by lupus — which can progress to permanent damage if untreated, a key reason monitoring matters even during quiet periods.

How Lupus Is Diagnosed

There is no single definitive test, which is part of why diagnosis can take time — on average, nearly six years from first symptoms, per the Lupus Foundation of America. Rheumatologists combine medical history, physical exam, and lab testing: blood tests for autoantibodies (such as antinuclear antibodies), urine tests for kidney involvement, and sometimes a skin or kidney biopsy, while ruling out other conditions with overlapping symptoms.

Standard Treatment Today

There is no cure, but treatment has improved substantially, and most people with lupus can manage the disease and lead full lives with appropriate care. Goals center on controlling inflammation, preventing flares, and protecting organs long-term. Antimalarials, especially hydroxychloroquine, are a mainstay for most patients, linked to fewer flares and better long-term outcomes. Corticosteroids control inflammation during flares, though doctors limit long-term use given side effects, and immunosuppressants calm an overactive immune system in more active disease. A genuinely encouraging development has been targeted biologic therapy after decades without new options: belimumab (Benlysta, 2011) and anifrolumab (Saphnelo, 2021, the first therapy blocking type 1 interferon activity) offer more precise ways to quiet lupus's immune dysfunction in appropriate patients — real progress in a field that went roughly fifty years between new drug approvals.

Where Stem Cell and Cell Therapy Research Currently Stands

Beyond conventional drugs, researchers are exploring cell-based approaches meant to reset the immune system rather than simply suppress it, and early signals are genuinely promising. Centers including UCL/UCLH in the UK and UC Irvine in the US have begun early-phase CAR T-cell trials for severe, treatment-resistant lupus, with UCL researchers describing initial results as "early promise." One notable approach, an "off-the-shelf" therapy called FT819 made from induced pluripotent stem cells rather than a patient's own donor cells, has shown encouraging early Phase 1 results. These remain small, early studies with open questions about durability and safety. Our dedicated article, Stem Cell Therapy for Lupus, covers this research in full.

Bottom Line

Lupus is a complex, lifelong autoimmune disease that can affect nearly any part of the body, and remains more common — and more serious for some communities — than many realize. While there is no cure, earlier diagnosis and newer targeted biologics have genuinely improved outcomes compared with a generation ago. Early cell-based research adds a hopeful new frontier, though it remains experimental. Anyone with persistent, unexplained fatigue, joint pain, or unusual rashes should talk with a qualified healthcare provider, since early diagnosis and consistent care remain the most reliable ways to protect long-term health.